THIS CLINICAL ANSWER IS UPDATED
This Cochrane Clinical Answer evaluates peroxisome proliferator-activated receptor gamma agonists to prevent recurrent stroke and other vascular events.
Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.
A subscription to THE COCHRANE LIBRARY is required.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.